Brand: Boehringer Ingelheim

Vetmedin Oral Solution for Dogs- 1.5mg/ml 50ml bottle

£33.49

Vetmedin oral solution is used in the treatment of heart disease in dogs

Legal Category : POM-V

This product requires a prescription for purchase

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

View POM

Delivery & Returns

Secure Checkout with

Accredited Retailer

Vetmedin 1.5 mg/ml oral solution for dogs.

For the treatment of canine congestive heart failure originating from dilated
cardiomyopathy or valvular insufficiency (mitral and/or tricuspid valve
regurgitation).
For the treatment of dilated cardiomyopathy in the preclinical stage
(asymptomatic with an increase in left ventricular end-systolic and end-diastolic
diameter) in Doberman Pinschers following echocardiographic diagnosis of
cardiac disease
For the treatment of dogs with myxomatous mitral valve disease (MMVD) in the
preclinical stage (asymptomatic with a systolic mitral murmur and evidence of
increased heart size) to delay the onset of clinical symptoms of heart failure
Do not use pimobendan in hypertrophic cardiomyopathies or in diseases in
which an improvement in cardiac output cannot be achieved for functional or
anatomical reasons (e.g., aortic stenosis)

Product Description

Vetmedin 1.5 mg/ml oral solution for dogs.

For the treatment of canine congestive heart failure originating from dilated
cardiomyopathy or valvular insufficiency (mitral and/or tricuspid valve
regurgitation).
For the treatment of dilated cardiomyopathy in the preclinical stage
(asymptomatic with an increase in left ventricular end-systolic and end-diastolic
diameter) in Doberman Pinschers following echocardiographic diagnosis of
cardiac disease
For the treatment of dogs with myxomatous mitral valve disease (MMVD) in the
preclinical stage (asymptomatic with a systolic mitral murmur and evidence of
increased heart size) to delay the onset of clinical symptoms of heart failure
Do not use pimobendan in hypertrophic cardiomyopathies or in diseases in
which an improvement in cardiac output cannot be achieved for functional or
anatomical reasons (e.g., aortic stenosis)